Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × COVID-19 × COVID-19 Serotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 COVID-19 1

Interventions

sotrovimab 1 remdesivir 1 ciclesonide 1 Standard of Care 1 Niclosamide 1 COVID-19 Serotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04873414 2021-06-02

PlaSenTer

National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

Phase 2/3 Unknown

COVID-19, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡